The FDA has flagged it for severe side effects
That said, GLP-1s are highly priced branded drugs, making the spread between the buy-side and sell-side discounts very thin, with our estimate at 0.2%
Combined with the metabolic reset that significant weight loss provides, this stack addresses aging from both the cellular and systemic levels
For comparison, in the table below, we also show those GLP-1 agonists with active ingredients only approved for treatment of diabetes that have less potential for off-label weight loss use (Bydureon BCise, Trulicity)
Americans consume approximately 15 teaspoons of added sugar each day on average
Providers need to know about recent serological testing results, nutritional deficiencies, and other autoimmune conditions, as these factors influence treatment planning